Bonraybio Co., Ltd. (TPE:6955)
Taiwan · Delayed Price · Currency is TWD 132.50
-0.50 (-0.38%)
At close: Jun 18, 2026
Bonraybio Market Cap
Bonraybio has a market cap or net worth of 3.29 billion as of June 18, 2026. Its market cap has decreased by -7.65% in one year.
Market Cap
3.29B
Enterprise Value
2.73B
Revenue
319.67M
Ranking
n/a
PE Ratio
32.24
Stock Price
132.50
Market Cap Chart
Since July 25, 2023, Bonraybio's market cap has increased from 1.48B to 3.29B, an increase of 122.60%. That is a compound annual growth rate of 31.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 3.29B | -10.47% |
| Dec 31, 2025 | 3.67B | 24.12% |
| Dec 31, 2024 | 2.96B | 101.25% |
| Dec 29, 2023 | 1.47B | -0.46% |
| Jul 25, 2023 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Delta Asia International | 5.94B |
| Hi-Clearance | 5.83B |
| WeLeader Biomedical | 3.23B |
| A Plus Biotechnology | 2.49B |
| Applied BioCode | 2.48B |
| Medimaging Integrated Solution | 2.39B |
| Wellell | 2.36B |
| OK Biotech | 2.16B |